SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for COVETRUS, INC. (CIK 0001752836) — May 13, 2020

COVETRUS, INC. (CIK 0001752836)
Date: May 13, 2020 · CIK: 0001752836 · Accession: 0000000000-20-004247

AI Filing Summary & Sentiment

File numbers found in text: 001-38794

Date
May 13, 2020
Author
Not clearly detected
Form
UPLOAD
Company
COVETRUS, INC. (CIK 0001752836)

Letter

United States securities and exchange commission logo May 13, 2020 Stuart Gleichenhaus Interim Chief Financial Officer Covetrus, Inc. 7 Custom House Street Portland, ME 04101 Re:Covetrus, Inc. Form 10-K for the Year Ended December 31, 2019 Filed March 3, 2020 File No. 001-38794 Dear Mr. Gleichenhaus: We have limited our review of your filing to the financial statements and related disclosures and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to these comments within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response. After reviewing your response to these comments, we may have additional comments. Form 10-K for the Year Ended December 31, 2019 Notes to Consolidated Financial Statements Note 7. Goodwill and Other Intangible Assets, Net Other Intangible Assets, Net, page 67 1.Please disclose the useful lives of each major intangible asset class for the Vets First Choice acquisition at December 31, 2019. Refer to ASC 350-30-50-1(a)(3). 2.Intangibles for product development increased by $400 million in 2019, apparently due to $50 million of product formulas and $350 million of developed technologies obtained in the acquisition of Vets First Choice in February 2019. It is unclear from your disclosure here and in "Cost of Sales" on page 60 which major intangible asset classes are amortized to cost of sales versus selling, general and administrative (SG&A) expenses. Please tell us how you determine to classify the amortization for each major class of intangible assets as cost of sales or SG&A and the rationale for your determination.

FirstName LastNameStuart Gleichenhaus Comapany NameCovetrus, Inc. May 13, 2020 Page 2 FirstName LastName Stuart Gleichenhaus Covetrus, Inc. May 13, 2020 Page 2 In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. You may contact Robert Shapiro at (202) 551-3273 or Doug Jones at (202) 551-3309 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: Ms. Erin Brennan

Show Raw Text
United States securities and exchange commission logo
May 13, 2020
Stuart Gleichenhaus
Interim Chief Financial Officer
Covetrus, Inc.
7 Custom House Street
Portland, ME 04101
Re:Covetrus, Inc.
Form 10-K for the Year Ended December 31, 2019
Filed March 3, 2020
File No. 001-38794
Dear Mr. Gleichenhaus:
            We have limited our review of your filing to the financial statements and related
disclosures and have the following comments.  In some of our comments, we may ask you to
provide us with information so we may better understand your disclosure.
            Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond.  If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
            After reviewing your response to these comments, we may have additional comments.
Form 10-K for the Year Ended December 31, 2019
Notes to Consolidated Financial Statements
Note 7. Goodwill and Other Intangible Assets, Net
Other Intangible Assets, Net, page 67
1.Please disclose the useful lives of each major intangible asset class for the Vets First
Choice acquisition at December 31, 2019.  Refer to ASC 350-30-50-1(a)(3).
2.Intangibles for product development increased by $400 million in 2019, apparently due to
$50 million of product formulas and $350 million of developed technologies obtained
in the acquisition of Vets First Choice in February 2019.  It is unclear from your
disclosure here and in "Cost of Sales" on page 60 which major intangible asset classes are
amortized to cost of sales versus selling, general and administrative (SG&A) expenses.
Please tell us how you determine to classify the amortization for each major class of
intangible assets as cost of sales or SG&A and the rationale for your determination.

 FirstName LastNameStuart Gleichenhaus
 Comapany NameCovetrus, Inc.
 May 13, 2020 Page 2
 FirstName LastName
Stuart Gleichenhaus
Covetrus, Inc.
May 13, 2020
Page 2
            In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
            You may contact Robert Shapiro at (202) 551-3273 or Doug Jones at (202) 551-3309
with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc:       Ms. Erin Brennan